Unichem Laboratories Limited (NSE:UNICHEMLAB)
624.00
+15.70 (2.58%)
May 22, 2025, 3:30 PM IST
Revenue by Product
Fiscal year is April - March.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
---|---|---|---|---|---|---|
Period Ending | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | Mar '19 Mar 31, 2019 | 2016 - 2018 |
Formulations | 15.20B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Formulations Growth | 31.21% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Bulk Drugs and Chemicals | 1.38B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Bulk Drugs and Chemicals Growth | -4.53% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Export Benefits | 377.69M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Export Benefits Growth | 114.92% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | 97.09M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | -57.84% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | 97.09M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | -57.84% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is April - March.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
---|---|---|---|---|---|---|
Period Ending | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | Mar '19 Mar 31, 2019 | 2016 - 2018 |
Other | 6.11B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | 26.02% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
United States | 10.06B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
United States Growth | 28.02% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
India | 409.80M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
India Growth | 27.22% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | 6.11B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | 26.02% |
Log In |
Log In |
Log In |
Log In | Upgrade
|